Life Science Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Life Science Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiology
Cerebral embolic protection and carotid stent systems
April 10th, 2007
High-risk surgical patients in community hospital settings can safely benefit from the use of new embolus-removing and stent-inserting systems, according to a study presented at the American College of Cardiology’s Innovation in Intervention: i2 Summit in New Orleans, La. The use of these systems to treat carotid artery blockage has only been studied in limited clinical trials, prior to FDA approval, in the pivotal SECuRITY (Registry Study to Evaluate the Neuroshield Bare Wire Cerebral Protection System and X-Act Stent in Patients at High Risk for Carotid Endarterectomy, 2004) study. Innovation in Intervention: i2 Summit is an annual meeting for practicing...
Source: Life Science Weekly (2007-04-10)
|
